Hiya, some external confirmation from the wall street journal of the reimbursement of Provenge (dndn) from Medicare.
http://online.wsj.com/article/BT-CO-20110630-715091.html
"The Centers for Medicare and Medicaid Services said Thursday it has approved nationwide Medicare reimbursement for the drug Provenge from Dendreon for use in certain advanced cases of metastatic prostate cancer, The Wall Street Journal reported. The drug, which seeks to harness a patient's own immune system to fight prostate cancer, will cost about $93,000 for a full course of therapy. Shares gained 1.4% after-hours to $40."
cheers billdah
medicare approves provenge, page-6
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
31.0¢ |
Change
-0.005(1.59%) |
Mkt cap ! $450.9M | |||
| Open | High | Low | Value | Volume |
| 30.5¢ | 32.0¢ | 30.5¢ | $922.9K | 2.963M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 149460 | 30.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 30000 | 1 |
View Market Depth
| Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
| IMM (ASX) Chart |